Can vitamin D supplementation be dangerous? 25-Hydroxyvitamin D and 1,25-hydroxyvitamin D concentration in healthy population and primary hyperparathyroidism: a single-center experience and literature review.
Obołończyk &, Berendt-Obołończyk M, et al. • Frontiers in endocrinology • 2025
1,25-OH-D serum concentration and vitamin D activation ratio (VD-AR) are significantly higher in PHPT patients than in healthy population, and higher VD-AR increases the probability of hypercalcemia above 11 mg/dL and indication for parathyroidectomy.
Key Findings
Results
Median 1,25-OH-D3 concentrations were significantly different across all groups, being highest in PHPT patients qualified for surgery, intermediate in those managed conservatively, and lowest in controls.
Median 1,25-OH-D3 was 91.1 pg/mL in SG2 (surgical PHPT), 64.05 pg/mL in SG1 (conservative PHPT), and 46.20 pg/mL in CG (controls).
Statistically significant differences were found between the medians of 1,25-OH-D between all pairs of groups (SG1 vs. SG2; SG1 vs. CG; SG2 vs. CG).
Study group consisted of 85 PHPT patients and 51 controls without calcium-phosphate imbalance.
Results
Median 25-OH-D3 concentrations did not follow the same pattern as 1,25-OH-D3 across groups.
Median 25-OH-D3 was 30.00 ng/mL in CG, 32.75 ng/mL in SG1, and 27.6 ng/mL in SG2.
Unlike 1,25-OH-D3, 25-OH-D3 levels were not highest in the surgically treated PHPT subgroup.
The divergence between 25-OH-D3 and 1,25-OH-D3 patterns across groups motivated introduction of the VD-AR metric.
Results
The vitamin D activation ratio (VD-AR), defined as the ratio of 1,25-OH-D to 25-OH-D, was highest in PHPT patients qualified for surgery.
Median VD-AR was 3.32 in SG2 (surgical PHPT), lower in SG1 (conservative PHPT), and lowest in CG.
Statistically significant differences in VD-AR were found between all pairs of groups.
VD-AR was introduced as a novel ratio to capture the relative activation of vitamin D in the context of PHPT.
Results
Higher VD-AR was independently associated with greater probability of hypercalcemia above 11 mg/dL in a logistic regression model.
In the logit model for calcium, the structural parameter for VD-AR was statistically significant.
The model correctly classified 74.1% of cases.
Higher VD-AR value was associated with greater probability of serum calcium exceeding 11 mg/dL.
Results
Both higher VD-AR and higher iPTH independently predicted indication for parathyroidectomy in a logistic regression model.
In the logit model for indication for parathyroidectomy, the structural parameters for both VD-AR and iPTH were statistically significant at the 0.05 significance level.
The model correctly classified 72.9% of cases.
Higher VD-AR and independently higher serum iPTH concentration each increased the probability of surgical indication.
Results
A VD-AR cut-off of 3.3 was identified as clinically relevant.
The authors suggest VD-AR cut-off of 3.3 as clinically relevant based on the study findings.
This cut-off was derived in the context of distinguishing PHPT patients requiring surgery from those managed conservatively and from healthy controls.
The clinical relevance relates to predicting hypercalcemia severity and surgical indication in PHPT.
Background
The study examined the potential danger of vitamin D supplementation in the context of PHPT, where PTH-driven conversion of 25-OH-D to 1,25-OH-D may be dysregulated.
PHPT is characterized by excessive PTH secretion from parathyroid cells insensitive to suppressive effects of hypercalcemia.
The impact of both 25-OH-D and 1,25-OH-D in PHPT pathogenesis was described as 'still poorly researched' prior to this study.
The study design compared PHPT patients (n=85) divided into surgical (SG2) and conservative (SG1) subgroups against healthy controls (n=51).
Obołończyk &, Berendt-Obołończyk M, Sworczak K, Karwacka-Bujak I, Majerowska E, Renke M. (2025). Can vitamin D supplementation be dangerous? 25-Hydroxyvitamin D and 1,25-hydroxyvitamin D concentration in healthy population and primary hyperparathyroidism: a single-center experience and literature review.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2025.1700345